Evidence map›Paper›PMID 35731848›Full record

ReviewThe British journal of radiology2022

Interventional oncology: new techniques and new devices.

Joseph A Breuer, K Hamzah Ahmed, Fares Al-Khouja, Anvesh R Macherla, Jackline M Muthoka, Nadine Abi-Jaoudeh

Abstract readReview
In one paragraph

Review in The British journal of radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Joseph A BreuerSchool of Medicine, University of California Irvine, Irvine, USA.
K Hamzah AhmedSchool of Medicine, University of California Irvine, Irvine, USA.
Fares Al-KhoujaSchool of Medicine, University of California Irvine, Irvine, USA.
Anvesh R MacherlaSchool of Medicine, University of California Irvine, Irvine, USA.
Jackline M MuthokaSchool of Medicine, University of California Irvine, Irvine, USA.
Nadine Abi-JaoudehDepartment of Radiological Sciences, University of California Irvine, Orange, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interventional oncology is a rapidly emerging field in the treatment of cancer. Minimally invasive techniques such as transarterial embolization with chemotherapeutic and radioactive agents are established therapies and are found in multiple guidelines for the management of primary and metastatic liver lesions. Percutaneous ablation is also an alternative to surgery for small liver, renal, and pancreatic tumors. Recent research in the niche of interventional oncology has focused on improving outcomes of established techniques in addition to the development of novel therapies. In this review, we address the recent and current advancements in devices, technologies, and techniques of chemoembolization and ablation: thermal ablation, histotripsy, high-intensity focused ultrasound, embolization strategies, liquid embolic agents, and local immunotherapy/antiviral therapies.

Indexed as

Embolization, TherapeuticLiver NeoplasmsAntiviral AgentsHumansImmunotherapyAntiviral Agents

Identifiers

PMID35731848
PMCPMC9815742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.